# Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19)

> **NCT04307693** · PHASE2 · TERMINATED · sponsor: **Asan Medical Center** · enrollment: 65 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Lopinavir/ritonavir
- **DRUG:** Hydroxychloroquine sulfate

## Key facts

- **NCT ID:** NCT04307693
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-03-11
- **Primary completion:** 2020-04-30
- **Final completion:** 2020-04-30
- **Target enrollment:** 65 (ACTUAL)
- **Why stopped:** Terminated early because no patients were further enrolled since mid-Apr 2020.
- **Last updated:** 2020-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04307693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04307693, "Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04307693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*